Skip to main content
SpringerLink
Log in

Insulin-dependent diabetes mellitus: Islet changes in relation to etiology and pathogenesis

  • Review
  • Published:
Endocrine Pathology Aims and scope Submit manuscript

An Erratum to this article was published on 01 March 1998

Abstract

Type I and type II diabetes are the most common types of diabetes. The ratio of type I to type II diabetes is about 1∶9. Type I diabetes is caused by absolute insulin deficiency and is therefore referred to as insulin-dependent diabetes. The disease becomes manifest clinically in childhood or adolescence (“juvenile diabetes”), though onset in adulthood is increasingly being observed. Morphologically a subtotal (>80%) to total loss of β-cells in the pancreatic islets occurs. Lymphocytic insulitis, which disappears after the β-cells have been totally destroyed, is pathogneumonic of type I diabetes. This insulitis is an expression of an autoimmune event that is triggered by a multitude of factors. An important factor appears to be a genetic predisposition (human leukocyte antigen [HLA] DR3/DR4/DQ8) in connection with as-yet-unknown environmental factors (e.g., viruses). Autoantibodies, such as islet cell cytoplasmic antibodies (ICA), insulin autoantibodies (IAA), and/or autoantibodies to the gamma-aminobutyric acid (GABA)-synthesizing enzyme glutamic acid carboxylase (GAD), are already detectable in a prediabetic phase, though it is not possible to predict the time of clinical onset. The course of the disease is dependent on age. Young children require insulin therapy sooner than juveniles or adults.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Püschel K, Lockemann U, Saukko P, Klöppel G, Eisenmenger W. Scharlatanerie mit tödlichem Ausgang. Münch Med Wochenschr 138:287–290, 1996.

    Google Scholar 

  2. WHO Expert Committee on Diabetes Mellitus. 2nd report. Technical report series. 1980.

  3. Zimmet P. Type 2 (non-insulin dependent) diabetes: an epidemiological overview. Diabetologia 22:399–411, 1982.

    Article  PubMed  CAS  Google Scholar 

  4. Gepts W. Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 14:619–633, 1965.

    PubMed  CAS  Google Scholar 

  5. Foulis AK, Stewart JA. The pancreas in recent-onset type 1 (insulin-dependent) diabetes mellitus: insulin content of islets, insulitis and associated changes in the exocrine acinar tissue. Diabetologia 26:456–461, 1984.

    Article  PubMed  CAS  Google Scholar 

  6. Klöppel G, Drenck CR, Oberholzer M, Heitz PU. Morphometric evidence for a striking B-cell reduction at the clinical onset of type 1 diabetes. Virchows Arch [A] Pathol Anat 403:441–452, 1984.

    Article  Google Scholar 

  7. LeCompte PM. “Insulitis” in early juvenile diabetes. Arch Pathol 66:450–457, 1958.

    CAS  Google Scholar 

  8. MacLean N, Ogilvie RF. Observations on the pancreatic islet tissue of young diabetic subjects. Diabetes 8:83–91, 1953.

    Google Scholar 

  9. Löhr M, Klöppel G. Residual insulin positivity and pancreatic atrophy in relation to duration of chronic type 1 (insulin-dependent) diabetes mellitus and microangiopathy. Diabetologia 30:757–762, 1987.

    Article  PubMed  Google Scholar 

  10. Rahier J, Goebbels RM, Henquin JC. Cellular composition of the human diabetic pancreas. Diabetologia 24:366–371, 1983.

    Article  PubMed  CAS  Google Scholar 

  11. Henderson JR, Daniel PM, Fraser PA. The pancreas as a single organ: the influence of the endocrine upon the exocrine part of the gland. Gut 22:158–167, 1981.

    Article  PubMed  CAS  Google Scholar 

  12. Korc M, Owerbach D, Quinto C, Rutter WJ. Pancreatic islet-acinar cell interaction: amylase messenger RNA levels are determined by insulin. Science 213:351–353, 1981.

    Article  PubMed  CAS  Google Scholar 

  13. Foulis AK, Liddle CN, Farquharson MA, Richmond JA, Weir RS. The histopathology of the pancreas in type 1 (insulin-dependent) diabetes mellitus: a 25-year review of deaths in patients under 20 years of age in the United Kingdom. Diabetologia 29:267–274, 1986.

    Article  PubMed  CAS  Google Scholar 

  14. Lernmark Å, Klöppel G, Stenger D, Vathanaprida C, Fält K, Landin-Olsson M, Baskin DG, Palmer JP, Gown AM, Petersen JS, Li L, Edenvall H, Mauseth RS. Heterogeneity of islet pathology in two infants with recent onset diabetes mellitus. Virchows Arch 425:631–640, 1995.

    Article  PubMed  CAS  Google Scholar 

  15. von Meyenburg H. Über “Insulitis” bei Diabetes. Schweiz Med Wochenschr 21:554–557, 1940.

    Google Scholar 

  16. Bottazzo GF, Dean BM, McNally JM, MacKay EH, Swift PGF, Gamble DR. In situ characterisation of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. N Engl J Med 313:353–360, 1985.

    Article  PubMed  CAS  Google Scholar 

  17. Hanninen A, Jalkanen S, Salmi M, Tolkkanen S, Nikolakaros G, Simell O. Macrophages, T cell receptor usage, and endothelial cell activation in the pancreas at the onset of insulin-dependent diabetes mellitus. J Clin Invest 90:1901–1910, 1992.

    PubMed  CAS  Google Scholar 

  18. Conrad B, Weidmann E, Trucco G, Rudert WA, Behboo R, Ricordi C, Rodriguez-Rilo H, Finegold D, Trucco M. Evidence for superantigen involvement in insulin-dependent diabetes mellitus aetiology. Nature 371:351–355, 1994.

    Article  PubMed  CAS  Google Scholar 

  19. Susman W. Atrophy of the adrenals associated with Addison's disease. J Pathol Bacteriol 33:749–760, 1930.

    Article  Google Scholar 

  20. Masi AT, Hartmann WH, Hahn BN, Abbey H, Shulmarn LE. Hashimoto's disease: a clinicopathological study with matched controls. Lancel i:123–126, 1965.

    Article  Google Scholar 

  21. Foulis AK, Jackson R, Farquharson MA. The pancreas in idiopathic Addison's disease: a search for a prediabetic pancreas. Histopathology 12:481–490, 1988.

    Article  PubMed  CAS  Google Scholar 

  22. Löhr M, Schmitt P, Klöppel G. Inselveränderungen beim Insulin-abhängigen Diabetes im Alter. Immunzytochemische Pankreas-untersuchungen bei einer diabetischen Patientin mit Hypothyreose. Pathologe 9:103–108, 1988.

    PubMed  Google Scholar 

  23. Handwerger BS, Fernandes G, Brown DM. Immune and autoimmune aspects of diabetes mellitus. Hum Pathol 11:338–352, 1980.

    Article  PubMed  CAS  Google Scholar 

  24. Junker K, Egeberg J, Kromann H, Nerup J. An autopsy study of the islets of Langerhans in acute-onset juvenile diabetes mellitus. Acta Pathol Microbiol Scand 85:699–706, 1977.

    CAS  Google Scholar 

  25. Orci L, Baetens D, Rufener C, Amherdt M, Ravazzola M, Studer P, Malaisse-Lagae F, Unger RH. Hypertrophy and hyperplasia of somatostatin-containing D-cells in diabetes. Proc Natl Acad Sci USA 73:1338–1342, 1976.

    Article  PubMed  CAS  Google Scholar 

  26. Gepts W, De Mey J. Islet cell survival determined by morphology: an immunocytochemical study of the islets of Langerhans in juvenile diabetes mellitus. Diabetes 27(Suppl. 1):251–261, 1978.

    PubMed  Google Scholar 

  27. Ogilvie RF. The endocrine pancreas in human and experimental diabetes. In: Cameron MP, O'Connor M, eds. Ciba Foundation Colloquia on Endocrinology. The aetiology of diabetes mellitus and its complications. London: Churchill Livingstone, 1964; pp. 49–74.

    Google Scholar 

  28. Atkinson MA, Bowman MA, Kuo-Jang K, Campbell L, Dush PJ, Shah SC, Simell O, Maclaren NK. Lack of immune responsiveness to bovine serum albumin in insulin-dependent diabetes. N Engl J Med 329: 1853–1858, 1993.

    Article  PubMed  CAS  Google Scholar 

  29. Atkinson MA, Maclaren NK. The pathogenesis of insulin-dependent diabetes mellitus. N Engl J Med 331:1428–1436, 1994.

    Article  PubMed  CAS  Google Scholar 

  30. Gorsuch AN, Lister J, Dean BM, Spencer KM, McNally JM, Bottazzo GF, Cudworth AG. Evidence for a long prediabetic period in type 1 (insulin-dependent) diabetes mellitus. Lancet ii:1363–1365, 1981.

    Article  Google Scholar 

  31. Baekkeskov S, Landin-Olsson M, Kristensen JK, Srikanta S, Bruining GJ, Mandrup-Poulsen T, De Beaufort C, Soeldner JS, Eisenbarth G, Lindgren F, Sundkvist G, Lernmark Å. Antibodies to a Mr 64,000 human islet cell antigen precede the clinical onset of insulin-dependent diabetes. J Clin Invest. 79:826–934, 1987.

    Google Scholar 

  32. Lernmark A. Islet cell antibodies. Diabet Med 4:285–292, 1987.

    Article  PubMed  CAS  Google Scholar 

  33. Atkinson MA, Maclaren NK, Scharp DW, Lacy PE, Riley WJ. 64,000 Mr autoantibodies as predictors of insulin-dependent diabetes. Lancet. 335:1357–1360, 1990.

    Article  PubMed  CAS  Google Scholar 

  34. Wilkin TJ. Insulin autoantibodies as markers for type I diabetes. Endocr Rev. 11:92–104, 1990.

    Article  PubMed  CAS  Google Scholar 

  35. Petersen JS, Russel S, Marshall MO, Kofod H, Buschard K, Cambon N, Karlsen AK, Boel E, Hagopian WA, Hejnaes KR, Moody A, Dyrberg T, Lernmark A, Madsen OD, Michielsen BK. Differential expression of glutamic acid decarboxylase in rat and human islets. Diabetes. 42:484–495, 1993.

    Article  PubMed  CAS  Google Scholar 

  36. Aguilar-Diosdado M, Parkinson D, Corbett JA, Kwon G, Marshall CA, Gingerich RL, Santiago JV, McDaniel ML. Potential autoantigens in IDDM: expression of carboxypeptidase-H and insulin but not glutamate decarboxylase on the β-cell surface. Diabetes 43:418–425, 1994.

    Article  PubMed  CAS  Google Scholar 

  37. Sibley RK, Sutherland DER, Goetz FC, Michael AF. Recurrent diabetes mellitus in the pancreatic iso- and allograft period: a light and electron microscopic and immunohistochemical analysis of four cases. Lab Invest. 53:132–144, 1985.

    PubMed  CAS  Google Scholar 

  38. Tydén G, Reinholt FP, Sundkvist G, Bolinder J. Recurrence of autoimmune diabetes mellitus in recipients of cadaveric pancreatic grafts. N Engl J Med 335:860–863, 1996.

    Article  PubMed  Google Scholar 

  39. Lampeter EF, Homberg M, Quabeck K, Schaefer UW, Wernet P, Bertrams J, Grosse-Wilde H, Gries FA, Kolb H. Transfer of insulin-dependent diabetes between HLA-identical siblings by bone marrow transplantation. Lancet 341:1243–1244, 1993.

    Article  PubMed  CAS  Google Scholar 

  40. Klöppel G. Experimental insulitis. In: Volk BW, Arquilla ER, Allen R, eds. The diabetic pancreas. New York: Plenum; 1985; pp. 467–492.

    Google Scholar 

  41. Griffin AC, Zhao W, Wegmann KW, Hickey WF. Experimental autoimmune insulitis: induction by T lymphocytes specific for a peptide of proinsulin. Am J Pathol 147:845–857, 1995.

    PubMed  CAS  Google Scholar 

  42. Ohashi PS, Oehen S, Bürki K, Pircher HP, Ohashi CT, Odermatt B, Malissen B, Zinkernagel R, Hengartner H. Ablation of “tolerance” and induction of diabetes by virus infection in viral antigen transgenic mice. Cell 65:305, 1991.

    Article  PubMed  CAS  Google Scholar 

  43. Like AA, Weringer EJ. Autoimmune diabetes in the Bio Breeding/Worcester rat. In: Lefebvre P, Pipeleers DG, eds. The pathology of the endocrine pancreas in diabetes, Berlin: Springer, 1988; pp 269–284.

    Google Scholar 

  44. Kolb H. Mouse models of insulin dependent diabetes: low-dose streptozocin-induced diabetes and nonobese diabetic (NOD) mice. Diabetes Metab Rev. 3:751–778, 1987.

    PubMed  CAS  Google Scholar 

  45. Castano L, Eisenbarth G. Type I diabetes: a chronic autoimmune disease of human, mouse and rat. Annu Rev Immunol. 8:647–679, 1990.

    Article  PubMed  CAS  Google Scholar 

  46. Itoh N, Hanafusa T, Yamagata K, Nakajima H, Tomita K, Tamura S, Inada M, Kawata M, Kono N, Kuwajima M, Matsuzawa Y. No detectable cytomegalovirus and Epstein-Barr virus genomes in the pancreas of recent-onset IDDM patients. Diabetologia 38:667–671, 1995.

    Article  PubMed  CAS  Google Scholar 

  47. Foulis AK, McGill M, Farquharson MA, Hilton DA. A search for evidence of viral infection in pancreases of newly diagnosed patients with IDDM. Diabetologia 40:53–61, 1997.

    Article  PubMed  CAS  Google Scholar 

  48. Nuovo JA, Baker JR, Wartofsky L, Lukes YG, Burman KD. Autoantibodies to insulin are present in sera of patients with autoimmune thyroid disease. Diabetes. 37:317–320, 1988.

    Article  PubMed  CAS  Google Scholar 

  49. Karjalainen J, Martin JM, Knip M, Ilonen J, Robinson BH, Savilahti E, Åkerblom HK, Dosch HM. A bovine albumine peptide as a possible trigger of insulin-dependent diabetes mellitus. N Engl J Med 327:302–307, 1992.

    Article  PubMed  CAS  Google Scholar 

  50. Bottazzo GF, Pujol-Borrell R, Hanafusa T. Hypothesis: role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity. Lancet. ii:1115–1119, 1983.

    Article  Google Scholar 

  51. Foulis AK, Farquharson MA. Aberrant expression of HLA-DR antigens by insulin-containing B-cells in recent-onset type I diabetes mellitus. Diabetes. 35:1215–1224, 1986.

    Article  PubMed  CAS  Google Scholar 

  52. Madsbad S. Prevalence of residual β cell function and its metabolic consequences in type 1 (insulin-dependent) diabetes. Diabetologia 24:141–147, 1983.

    PubMed  CAS  Google Scholar 

  53. Cudworth AG, Festenstein H. HLA genetic heterogeneity in diabetes mellitus. Br Med Bull 34:285–289, 1978.

    PubMed  CAS  Google Scholar 

  54. Wolf E, Spencer KM, Cudworth AG. The genetic susceptibility to type 1 (insulin-dependent) diabetes: analysis of the HLA-DR association. Diabetologia. 24:224–230, 1983.

    Article  PubMed  CAS  Google Scholar 

  55. Rossini AA, Mordes JP, Handler ES. Perspectives in diabetes: speculations on etiology of diabetes mellitus. Tumbler hypothesis. Diabetes 37:257–261, 1988.

    Article  PubMed  CAS  Google Scholar 

  56. Barnett AH, Epp C, Leslie RDG, Pyke DA. Diabetes in identical twins: a study of 200 pairs. Diabetologia 20:87–93, 1981.

    Article  PubMed  CAS  Google Scholar 

  57. Bärmeier H, McCulloch DK, Neifing JL, Warnock G, Rajotte RV, Palmer JP, Lernmark Å. Risk for developing type 1 (insulin-dependent) diabetes mellitus and the presence of islet 64K antibodies. Diabetologia. 34:727–733, 1991.

    Article  PubMed  Google Scholar 

  58. Rayfield EJ, Yoon IW. Role of viruses in diabetes. In: Cooperstein SJ, Watkins D, eds. The islets of Langerhans. New York: Academic, 1981; pp 427–451.

    Google Scholar 

  59. Szopa TM, Titchener PA, Portwood ND, Taylor KW. Diabetes mellitus due to viruses: some recent developments. Diabetologia. 36:687–695, 1993.

    Article  PubMed  CAS  Google Scholar 

  60. Kobayashi T, Nakanishi K, Kaijo H, Morinaga S, Sugimoto T, Murase T, Kosaka K. Pancreatic cytokeratin: an antigen of pancreatic exocrine cell autoantibodies in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 33:363–370, 1990.

    Article  PubMed  CAS  Google Scholar 

  61. Gladisch R, Hofmann W, Waldherr RI. Myokarditis und Insulitis nach Coxsackie-Virus-Infektion. Zeitschr Kardiol 65:849–855, 1976.

    Google Scholar 

  62. Yoon JW, Austin M, Onodera T, Notkins AL. Virus-induced diabetes mellitus: isolation of a virus from the pancreas of a child with diabetic ketoacidosis. N Engl J Med. 300:1173–1179, 1979.

    Article  PubMed  CAS  Google Scholar 

  63. Gorsuch AN, Spencer KM, Lister J, Wolf E, Bottazzo GF, Cudworth AG. Can future type 1 diabetes be predicted? A study in families of affected children. Diabetes. 31:862–866, 1982.

    Article  PubMed  CAS  Google Scholar 

  64. Millward BA, Alviggi L, Hoskins PJ, Johnston C, Heaton D, Bottazzo GF, Vergani D, Leslie RDG, Pyke DA. Immune changes associated with insulin dependent diabetes may remit without causing the disease: a study in identical twins. Br Med J. 292:793–796, 1986.

    CAS  Google Scholar 

  65. Gleichmann H, Zörcher B, Greulich B, Gries FA, Henrichs HR, Bertrams J, Kolb H. Correlation of islet cell antibodies and HLA-DR phenotypes with diabetes in adults. Diabetologia 27:90–92, 1984.

    Article  PubMed  Google Scholar 

  66. Groop L, Miettinen A, Groop PH, Meri S, Koskimies S, Bottazzo GF. Organ-specific autoimmunity and HLA-DR antigens as markers for B-cell destruction in patients with type II diabetes. Diabetes 37:99–103, 1988.

    Article  PubMed  CAS  Google Scholar 

  67. Doniach D, Bottazzo GF. Autoimmunity and the endocrine pancreas. Pathol Annu 7:327–346, 1977.

    CAS  Google Scholar 

  68. Ludvigsson J, Samuelsson U, Beauforts C, Deschamps I, Dorchy H, Drash A, Francois R, Herz G, New M, Schober E. HLA-DR 3 is associated with a more slowly progressive form of type 1 (insulin-dependent) diabetes. Diabetologia 29:207–210, 1986.

    Article  PubMed  CAS  Google Scholar 

  69. Wagner R, McNally JM, Bonifacio E, Genovese S, Foulis A, McGill M, Christie MR, Betterle C, Bosi E, Bottazzo GF. Lack of immunohistological changes in the islets of nondiabetic, autoimmune, polyendocrine patients with B-selective GAD-specific islet cell antibodies. Diabetes. 43:851–856, 1994.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, University of Kiel, Germany

    Günter Klöppel MD, PhD & Andreas Clemens MD

Authors
  1. Günter Klöppel MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Andreas Clemens MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Günter Klöppel MD, PhD.

Additional information

An erratum to this article is available at http://dx.doi.org/10.1007/BF02739957.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Klöppel, G., Clemens, A. Insulin-dependent diabetes mellitus: Islet changes in relation to etiology and pathogenesis. Endocr Pathol 8, 273–282 (1997). https://doi.org/10.1007/BF02739929

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02739929

Key Words

Search

Navigation